Malignant Lung Neoplasm — Trials

Malignant Lung Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,125 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,650
Recruiting: 1,432
Ph III recruiting: 179
Growth YoY: +7%
Industry share: 37%
Top sponsor: AstraZeneca
Termination share: 34.8%
Trials / 1,000 deaths: 20.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,491)

clinicaltrialsPublishedShowing 151–153 of 153 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00675168	Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice(PROLOG)	unknown	Phase 4	1,700	Odense University HospitalOTHER	1	Feb 19, 2009	clinicaltrials
NCT00440960	Anesthesia in Flexible Bronchoscopy for Lung Cancer Diagnostic	completed	Phase 4	—	Hospital PompeiaOTHER	1	Feb 27, 2007	clinicaltrials